Merit Medical Systems Reports Q1 2026 Earnings and Outlines Strategic Growth Initiatives
Merit Medical (MMSI) reported strong performance in Q1 2026, driven by a new operating model that improved accountability and execution. Organic growth of 3.7% was supported by demand in Cardiac Therapies and Endoscopy, while the OEM segment faced temporary challenges due to inventory destocking and macroeconomic factors.
Tickers: $MMSI
Topics: acquisition earnings free_cash_flow guidance operational_performance